{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:46:32Z","timestamp":1774867592040,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1124\/jpet.114.220293","type":"journal-article","created":{"date-parts":[[2014,12,25]],"date-time":"2014-12-25T06:05:06Z","timestamp":1419487506000},"page":"480-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Bias Analyses of Preclinical and Clinical D2 Dopamine Ligands: Studies with Immediate and Complex Signaling Pathways"],"prefix":"10.1016","volume":"352","author":[{"given":"Tarsis F.","family":"Brust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin D.","family":"Burris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val J.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.220293_bib1","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1073\/pnas.1104807108","article-title":"Discovery of \u03b2-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy","volume":"108","author":"Allen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.220293_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.114.220293_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1098\/rspb.1983.0093","article-title":"Operational models of pharmacological agonism","volume":"220","author":"Black","year":"1983","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1124\/jpet.114.220293_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/mol.66.1.106","article-title":"Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery","volume":"66","author":"Bohn","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/35047086","article-title":"Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"key":"10.1124\/jpet.114.220293_bib6","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1124\/jpet.114.220293_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bcp.2014.10.014","article-title":"New functional activity of aripiprazole revealed: robust antagonism of D2 dopamine receptor-stimulated G\u03b2\u03b3 signaling","volume":"93","author":"Brust","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.220293_bib9","first-page":"e51218","article-title":"Drug-induced sensitization of adenylyl cyclase: assay streamlining and miniaturization for small molecule and siRNA screening applications","volume":"83","author":"Conley","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1124\/jpet.114.220293_bib10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tips.2006.06.002","article-title":"Higher-order organization and regulation of adenylyl cyclases","volume":"27","author":"Cooper","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.114.220293_bib11","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1096\/fj.07-102459","article-title":"Beta-arrestins specifically constrain beta2-adrenergic receptor signaling and function in airway smooth muscle","volume":"22","author":"Deshpande","year":"2008","journal-title":"FASEB J"},{"key":"10.1124\/jpet.114.220293_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.110.231308","article-title":"Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology","volume":"109","author":"DeWire","year":"2011","journal-title":"Circ Res"},{"key":"10.1124\/jpet.114.220293_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00210-008-0260-4","article-title":"On the analysis of ligand-directed signaling at G protein-coupled receptors","volume":"377","author":"Ehlert","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib14","doi-asserted-by":"crossref","first-page":"210324","DOI":"10.1155\/2012\/210324","article-title":"Dopamine D(2) receptor-mediated heterologous sensitization of AC5 requires signalosome assembly","volume":"2012","author":"Ejendal","year":"2012","journal-title":"J Signal Transduct"},{"key":"10.1124\/jpet.114.220293_bib15","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1529\/biophysj.105.077818","article-title":"Resonant waveguide grating biosensor for living cell sensing","volume":"91","author":"Fang","year":"2006","journal-title":"Biophys J"},{"key":"10.1124\/jpet.114.220293_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/356159a0","article-title":"Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits","volume":"356","author":"Federman","year":"1992","journal-title":"Nature"},{"key":"10.1124\/jpet.114.220293_bib17","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1038\/srep03828","article-title":"Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed \u03b22-adrenergic receptors","volume":"4","author":"Ferrie","year":"2014","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.114.220293_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/mol.66.1.97","article-title":"Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states","volume":"66","author":"Gay","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib19","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1124\/jpet.107.120857","article-title":"Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi\/o,Gs, and G15","volume":"321","author":"Griffin","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.220293_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2014.06.003","article-title":"What is pharmacological \u2018affinity\u2019? Relevance to biased agonism and antagonism","volume":"35","author":"Kenakin","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.114.220293_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrd3954-c2","article-title":"Measurements of ligand bias and functional affinity","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.114.220293_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.114.220293_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.114.220293_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0026-895X(25)14062-5","article-title":"A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data","volume":"17","author":"Kent","year":"1980","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.neuropharm.2008.03.015","article-title":"Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling","volume":"54","author":"Klewe","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.220293_bib26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.220293_bib27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by beta-arrestins","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"key":"10.1124\/jpet.114.220293_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1124\/mol.111.073072","article-title":"Understanding molecular recognition by G protein \u03b2\u03b3 subunits on the path to pharmacological targeting","volume":"80","author":"Lin","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib29","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.0803522105","article-title":"Antagonism of dopamine D2 receptor\/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics","volume":"105","author":"Masri","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.220293_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cell.2013.01.008","article-title":"The dynamic process of \u03b2(2)-adrenergic receptor activation","volume":"152","author":"Nygaard","year":"2013","journal-title":"Cell"},{"key":"10.1124\/jpet.114.220293_bib31","first-page":"92","article-title":"Dopamine D-4 and D-2L receptor stimulation of the mitogen-activated protein kinase pathway is dependent on transactivation of the platelet-derived growth factor receptor","volume":"60","author":"Oak","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbrc.2008.10.044","article-title":"Roles of G protein and beta-arrestin in dopamine D2 receptor-mediated ERK activation","volume":"377","author":"Quan","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.114.220293_bib33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrd3954-c1","article-title":"Quantifying biased agonism: understanding the links between affinity and efficacy","volume":"12","author":"Rajagopal","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.114.220293_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/mol.111.072801","article-title":"Quantifying ligand bias at seven-transmembrane receptors","volume":"80","author":"Rajagopal","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib35","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/nprot.2011.386","article-title":"Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells","volume":"6","author":"Schr\u00f6der","year":"2011","journal-title":"Nat Protoc"},{"key":"10.1124\/jpet.114.220293_bib36","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.220293_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.220293_bib38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1124\/mol.108.047472","article-title":"Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells","volume":"74","author":"Vidi","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib39","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1073\/pnas.0906034106","article-title":"Targeted transgenesis reveals discrete attenuator functions of GRK and PKA in airway beta2-adrenergic receptor physiologic signaling","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.220293_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.302.1.1","article-title":"Molecular mechanisms for heterologous sensitization of adenylate cyclase","volume":"302","author":"Watts","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.220293_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pharmthera.2004.12.005","article-title":"Sensitization of adenylate cyclase by G\u03b1 i\/o-coupled receptors","volume":"106","author":"Watts","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.114.220293_bib42","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0026-895X(25)09399-X","article-title":"Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors","volume":"50","author":"Watts","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/mol.52.2.181","article-title":"Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors","volume":"52","author":"Watts","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.220293_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","article-title":"Therapeutic potential of \u03b2-arrestin- and G protein-biased agonists","volume":"17","author":"Whalen","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.114.220293_bib45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/1087057108321531","article-title":"A homogeneous enzyme fragment complementation-based beta-arrestin translocation assay for high-throughput screening of G-protein-coupled receptors","volume":"13","author":"Zhao","year":"2008","journal-title":"J Biomol Screen"},{"key":"10.1124\/jpet.114.220293_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/mol.113.086322","article-title":"Arginine vasopressin enhances cell survival via a G protein-coupled receptor kinase 2\/\u03b2-arrestin1\/extracellular-regulated kinase 1\/2-dependent pathway in H9c2 cells","volume":"84","author":"Zhu","year":"2013","journal-title":"Mol Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.220293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:57:57Z","timestamp":1739987877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524189677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0022356524189677"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.220293","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bias Analyses of Preclinical and Clinical D2 Dopamine Ligands: Studies with Immediate and Complex Signaling Pathways","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.220293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}